Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Sedative-Hypnotic Drugs Market Report 2024

Sedative-Hypnotic Drugs Global Market Report 2024 – By Drug Class (Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By Disease Type (Sleep Disorders, Anesthesia, Pain, Other Disease Types), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Sedative-Hypnotic Drugs Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : June 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Sedative-Hypnotic Drugs Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Sedative-Hypnotic Drugs Market Definition And Segments

A sedative-hypnotic drug refers to a chemical substance utilized to alleviate tension and anxiety, promote a sense of calm (sedative effect), or facilitate sleep induction (hypnotic effect). Sedatives or hypnotics act to suppress the limbic system of the brain, which governs emotional and behavioral reactions, as well as the reticular formation, responsible for regulating sleep patterns and overall consciousness.

The main types of sedative-hypnotic drugs include benzodiazepines, barbiturates, antihistamines, nonbenzodiazepine, and others. Benzodiazepines refer to a class of medications that decrease activity in the brain and nervous system and are used to alleviate symptoms of anxiety and insomnia due to their tranquilizing effects on the central nervous system. It can be administered through various routes, including oral, parenteral, and others, to cure several diseases, such as sleep disorders, anesthesia, pain, and others. These are sold through various distribution channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and others, to several end-users, including hospitals, specialty clinics, home care, and others.

The sedative-hypnotic drugs market covered in this report is segmented –

1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes

2) By Route of Administration: Oral, Parenteral, Other Routes of Administration

3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

The sedative-hypnotic drugs market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.57 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to the expansion of direct-to-consumer advertising, increased stress levels, higher prevalence of sleep disorders, expansion of direct-to-consumer advertising, and aging populations.

The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.00 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing healthcare infrastructure, rising disposable incomes, rising incidence of lifestyle-related disorders, growing consumer interest in natural and herbal sleep aids, and expansion of telemedicine services. Major trends in the forecast period include a growing preference for non-benzodiazepine sedative-hypnotic drugs, innovations in drug delivery technologies, increasing focus on personalized medicine, incorporation of digital health tools, and advent of benzodiazepines.

Stress Surge Predicted To Fuel Growth In The Sedative-Hypnotic Drugs Market

The increased stress levels are expected to propel the growth of the sedative-hypnotic drugs market going forward. Stress levels refer to the mental or emotional exhaustion individuals experience as a result of unavoidable or challenging circumstances. Several driving factors for stress levels include struggling to balance work responsibilities with personal life, inadequate coping mechanisms, and increasing work pressure among employees. Sedative-hypnotic drugs serve as pharmacological agents primarily intended to induce a state of calmness, diminish anxiety levels, and alleviate tension within individuals, often through their tranquilizing effects on the central nervous system. For instance, in December 2022, according to a survey of 2,212 American adults conducted by the American Psychiatric Association, a US-based national medical specialty organization, over 26% (more than one in four) of respondents indicated they expected to encounter increased stress at the beginning of 2023, marking a rise from the 20% reported in the previous year. Therefore, the increased stress levels are driving the growth of the sedative-hypnotic drugs market.

Major companies operating in the sedative-hypnotic drugs market are Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

Sedative-Hypnotic Drug Players Embrace Agitation Treatment Films For Competitive Advantage

Major companies operating in the sedative-hypnotic drugs market are focusing on expanding their product portfolio by adding products, such as innovative sublingual film, for acute treatment of agitation and to gain a competitive edge in the market. A sublingual film for the acute treatment of agitation refers to a thin, dissolvable film containing medication that is placed under the tongue for rapid absorption into the bloodstream. For instance, in April 2022, BioXcel Therapeutics Inc., a US-based biopharmaceutical company, announced the launch of IGALMI. It is a sublingual film designed for the acute management of agitation linked to schizophrenia or bipolar I or II disorder in adults. It is the first new acute treatment for schizophrenia or bipolar disorder-associated agitation in nearly a decade and represents a differentiated approach to helping patients manage this difficult and debilitating symptom. The approval of IGALMI marks a significant milestone, offering healthcare teams an innovative tool for managing agitation with its rapid onset of action and self-administered film format.

Eagle Pharmaceuticals Inc. Bolsters Portfolio With Acacia Pharma Group Plc Acquisition

In June 2022, Eagle Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Acacia Pharma Group plc for an undisclosed amount. Through this acquisition, Eagle Pharmaceuticals expanded its product portfolio by adding two drugs, 'BARHEMSYS' and 'BYFAVO', as the addition of these two products proliferated their presence in the acute care space. With this acquisition, both companies look forward to strengthening their position in the oncology and hospital spaces by addressing significant unmet clinical needs. Acacia Pharma Group plc is a UK-based pharmaceutical company that is involved in the manufacturing of sedative-hypnotic drugs.

North America was the largest region in the sedative-hypnotic drugs market in 2023. The regions covered in the sedative-hypnotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sedative-hypnotic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sedative-hypnotic drugs market consists of sales of tablets, capsules, injectables, and liquid formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The sedative-hypnotic drugs market research report is one of a series of new reports from The Business Research Company that provides sedative-hypnotic drugs market statistics, including sedative-hypnotic drugs industry global market size, regional shares, competitors with a sedative-hypnotic drugs market share, detailed sedative-hypnotic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the sedative-hypnotic drugs industry. This sedative-hypnotic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sedative-Hypnotic Drugs Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $3.57 billion
Revenue Forecast In 2033 $5 billion
Growth Rate CAGR of 8.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes
2) By Route of Administration: Oral, Parenteral, Other Routes of Administration
3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Sedative-Hypnotic Drugs Market Characteristics

    3. Sedative-Hypnotic Drugs Market Trends And Strategies

    4. Sedative-Hypnotic Drugs Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Sedative-Hypnotic Drugs Market Size and Growth

    5.1. Global Sedative-Hypnotic Drugs Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Sedative-Hypnotic Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Sedative-Hypnotic Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Sedative-Hypnotic Drugs Market Segmentation

    6.1. Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Benzodiazepines

    Barbiturates

    Antihistamines

    Nonbenzodiazepine

    Other Drug Class

    6.2. Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    Other Route of Administrations

    6.3. Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Sleep Disorders

    Anesthesia

    Pain

    Other Disease Types

    6.4. Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    Other Distribution Channels

    6.5. Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    Homecare

    Other End-Users

    7. Sedative-Hypnotic Drugs Market Regional And Country Analysis

    7.1. Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Sedative-Hypnotic Drugs Market

    8.1. Asia-Pacific Sedative-Hypnotic Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Sedative-Hypnotic Drugs Market

    9.1. China Sedative-Hypnotic Drugs Market Overview

    9.2. China Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Sedative-Hypnotic Drugs Market

    10.1. India Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Sedative-Hypnotic Drugs Market

    11.1. Japan Sedative-Hypnotic Drugs Market Overview

    11.2. Japan Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Sedative-Hypnotic Drugs Market

    12.1. Australia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Sedative-Hypnotic Drugs Market

    13.1. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Sedative-Hypnotic Drugs Market

    14.1. South Korea Sedative-Hypnotic Drugs Market Overview

    14.2. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Sedative-Hypnotic Drugs Market

    15.1. Western Europe Sedative-Hypnotic Drugs Market Overview

    15.2. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Sedative-Hypnotic Drugs Market

    16.1. UK Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Sedative-Hypnotic Drugs Market

    17.1. Germany Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Sedative-Hypnotic Drugs Market

    18.1. France Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Sedative-Hypnotic Drugs Market

    19.1. Italy Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Sedative-Hypnotic Drugs Market

    20.1. Spain Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Sedative-Hypnotic Drugs Market

    21.1. Eastern Europe Sedative-Hypnotic Drugs Market Overview

    21.2. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Sedative-Hypnotic Drugs Market

    22.1. Russia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Sedative-Hypnotic Drugs Market

    23.1. North America Sedative-Hypnotic Drugs Market Overview

    23.2. North America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Sedative-Hypnotic Drugs Market

    24.1. USA Sedative-Hypnotic Drugs Market Overview

    24.2. USA Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Sedative-Hypnotic Drugs Market

    25.1. Canada Sedative-Hypnotic Drugs Market Overview

    25.2. Canada Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Sedative-Hypnotic Drugs Market

    26.1. South America Sedative-Hypnotic Drugs Market Overview

    26.2. South America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Sedative-Hypnotic Drugs Market

    27.1. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Sedative-Hypnotic Drugs Market

    28.1. Middle East Sedative-Hypnotic Drugs Market Overview

    28.2. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Sedative-Hypnotic Drugs Market

    29.1. Africa Sedative-Hypnotic Drugs Market Overview

    29.2. Africa Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Sedative-Hypnotic Drugs Market Competitive Landscape And Company Profiles

    30.1. Sedative-Hypnotic Drugs Market Competitive Landscape

    30.2. Sedative-Hypnotic Drugs Market Company Profiles

    30.2.1. Sun Pharmaceutical Industries Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Pfizer Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck And Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bayer AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Sedative-Hypnotic Drugs Market Other Major And Innovative Companies

    31.1. Novartis AG

    31.2. Sanofi-Aventis AG

    31.3. AstraZeneca Plc

    31.4. Abbott Laboratories

    31.5. GlaxoSmithKline plc

    31.6. Takeda Pharmaceutical Company Limited

    31.7. Boehringer Ingelheim International GmbH

    31.8. Teva Pharmaceutical Industries Ltd.

    31.9. Mylan N.V.

    31.10. Fresenius Kabi AG

    31.11. Eli Lilly and Co.

    31.12. Aurobindo Pharma Limited

    31.13. Cipla Inc.

    31.14. Dr. Reddy’s Laboratories Ltd.

    31.15. Hikma Pharmaceuticals plc 

    32. Global Sedative-Hypnotic Drugs Market Competitive Benchmarking

    33. Global Sedative-Hypnotic Drugs Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Sedative-Hypnotic Drugs Market

    35. Sedative-Hypnotic Drugs Market Future Outlook and Potential Analysis

    35.1 Sedative-Hypnotic Drugs Market In 2028 - Countries Offering Most New Opportunities

    35.2 Sedative-Hypnotic Drugs Market In 2028 - Segments Offering Most New Opportunities

    35.3 Sedative-Hypnotic Drugs Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Sun Pharmaceutical Industries Inc. Financial Performance
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 79: Merck And Co. Inc. Financial Performance
  • Table 80: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Sun Pharmaceutical Industries Inc. Financial Performance
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 79: Merck And Co. Inc. Financial Performance
  • Figure 80: Bayer AG Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Pancreatic Cancer Drugs Market 2023 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users), And By Region, Opportunities And Strategies – Global Forecast To 2032
View Report
Acute Ischemic Stroke Drugs Global Market Report 2024 – By Type (Tablet, Capsule, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hospitals, Diagnostic Centers, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Ophthalmic Drugs Global Market Report 2024 – By Type (Prescription Drugs, Over-The-Counter Drugs), By Class (Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes), By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases), By Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Nephrology Drugs Global Market Report 2024 – By Drugs (Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Rheumatoid Arthritis Drugs Global Market Report 2024 – By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (BRMs), Other Drug Types), By Route Of Administration (Oral, Parenteral, Topical, Other Route Of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antispasmodics Drugs Global Market Report 2024 – By Drug (Dicyclomine Hydrochloride, Loperamide Hydrochloride, Other Drugs), By Indication (Irritable Bowel Syndrome, Stomach Cramps, Other Indications), By Route Of Administration (Oral, Parenteral, Other Modes Of Administrations), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Generic Musculoskeletal Disorders Drugs Global Market Report 2024 – By Treatment Type (Medication, Therapy, Surgery, Other Treatment Types), By Disorder Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pain Management Drugs Global Market Report 2024 – By Drug Class (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle sprain/strain, Bone fracture, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the sedative-hypnotic drugs market?

A sedative-hypnotic drug refers to a chemical substance utilized to alleviate tension and anxiety, promote a sense of calm (sedative effect), or facilitate sleep induction (hypnotic effect). Sedatives or hypnotics act to suppress the limbic system of the brain, which governs emotional and behavioral reactions, as well as the reticular formation, responsible for regulating sleep patterns and overall consciousness. For further insights on the sedative-hypnotic drugs market, request a sample here

How will the sedative-hypnotic drugs market drivers and restraints affect the sedative-hypnotic drugs market dynamics? What forces will shape the sedative-hypnotic drugs industry going forward?

The sedative-hypnotic drugs market major growth driver - Stress Surge Predicted To Fuel Growth In The Sedative-Hypnotic Drugs Market. For further insights on the sedative-hypnotic drugs market, request a sample here

What is the forecast market size or the forecast market value of the sedative-hypnotic drugs market?

The sedative-hypnotic drugs market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.57 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to the expansion of direct-to-consumer advertising, increased stress levels, higher prevalence of sleep disorders, expansion of direct-to-consumer advertising, and aging populations. The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.00 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing healthcare infrastructure, rising disposable incomes, rising incidence of lifestyle-related disorders, growing consumer interest in natural and herbal sleep aids, and expansion of telemedicine services. Major trends in the forecast period include a growing preference for non-benzodiazepine sedative-hypnotic drugs, innovations in drug delivery technologies, increasing focus on personalized medicine, incorporation of digital health tools, and advent of benzodiazepines. For further insights on the sedative-hypnotic drugs market, request a sample here

How is the sedative-hypnotic drugs market segmented?

The sedative-hypnotic drugs market is segmented
1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes
2) By Route of Administration: Oral, Parenteral, Other Routes of Administration
3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-UsersFor further insights on the sedative-hypnotic drugs market, request a sample here

Which region has the largest share of the sedative-hypnotic drugs market? What are the other regions covered in the report?

North America was the largest region in the sedative-hypnotic drugs market in 2023. The regions covered in the sedative-hypnotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the sedative-hypnotic drugs market, request a sample here.

Who are the major players in the sedative-hypnotic drugs market?

Major companies operating in the sedative-hypnotic drugs market are Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd. For further insights on the sedative-hypnotic drugs market, request a sample here.

What are the key trends in the sedative-hypnotic drugs market?

Major trend in the sedative-hypnotic drugs market - Sedative-Hypnotic Drug Players Embrace Agitation Treatment Films For Competitive Advantage. For further insights on the sedative-hypnotic drugs market, request a sample here.

What are the major opportunities in the sedative-hypnotic drugs market? What are the strategies for the sedative-hypnotic drugs market?

For detailed insights on the major opportunities and strategies in the sedative-hypnotic drugs market, request a sample here.

How does the sedative-hypnotic drugs market relate to the overall economy and other similar markets?

For detailed insights on sedative-hypnotic drugs market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the sedative-hypnotic drugs industry?

For detailed insights on the mergers and acquisitions in the sedative-hypnotic drugs industry, request a sample here.

What are the key dynamics influencing the sedative-hypnotic drugs market growth? SWOT analysis of the sedative-hypnotic drugs market.

For detailed insights on the key dynamics influencing the sedative-hypnotic drugs market growth and SWOT analysis of the sedative-hypnotic drugs industry, request a sample here.